Targeted Next-Generation Sequencing Reveals Clinically Actionable BRAF and ESR1 Mutations in Low-Grade Serous Ovarian Carcinoma. Academic Article uri icon

Overview

publication date

  • November 8, 2018

Identity

PubMed Central ID

  • PMC6394870

Scopus Document Identifier

  • 85075907153

Digital Object Identifier (DOI)

  • 10.1200/PO.18.00135

PubMed ID

  • 30828692

Additional Document Info

volume

  • 2018